<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01260402</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2010/12</org_study_id>
    <nct_id>NCT01260402</nct_id>
  </id_info>
  <brief_title>Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure.</brief_title>
  <acronym>EPI-ENDO</acronym>
  <official_title>Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Biventricular pacing is a validated treatment for patients suffering from heart failure
      resistant to medical treatment. However, up to 30% of the patients are non responsive to this
      strategy using the coronary sinus approach to pace the Left Ventricle (LV).

      It has been demonstrated that the magnitude of the improvement was highly dependant on the LV
      pacing site. The coronary sinus approach rarely offers more than 1 or 2 potential pacing
      sites. Resynchronisation using a transeptal approach to pace the left ventricle on the
      cardiology has been shown feasible on small series. We therefore would like to compare these
      two approached in a randomised prospective study to confirm the hypotheses that endocardial
      LV pacing by offering multiple choices for the pacing sites reduces the number of non
      responders and is associated with greater hemodynamic benefit when compared to the
      conventional coronary sinus approach.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the acute hemodynamic response judged by dP/dt max</measure>
    <time_frame>Visit 3 : implantation day, during pacing procedure</time_frame>
    <description>The primary outcome will be the acute hemodynamic response of the randomized pacing modality (endocardial vs epicardial Left Ventricle pacing) as judged by the highest gain in dP/dt max</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implant success rate</measure>
    <time_frame>Visit 3 : implantation day, end of pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of left ventricular pacing sites assessed</measure>
    <time_frame>Visit 3 : implantation day, end of pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pacing Procedure duration</measure>
    <time_frame>Visit 3 : implantation day, end of pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Per and post implantation complications rate</measure>
    <time_frame>Visit 4 : within 7 days after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post implantation echocardiography comparing spontaneous rhythm and biventricular pacing for left ventricle ejection fraction</measure>
    <time_frame>within 7 days after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post implantation echocardiography comparing spontaneous rhythm and biventricular pacing for mitral regurgitation</measure>
    <time_frame>within 7 days after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post implantation echocardiography comparing spontaneous rhythm and biventricular pacing for atrioventricular asynchronism</measure>
    <time_frame>within 7 days after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post implantation echocardiography comparing spontaneous rhythm and biventricular pacing for inter and intra-ventricular asynchronism</measure>
    <time_frame>within 7 days after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sensing performances of left ventricle pacing leads</measure>
    <time_frame>within 7 days after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pacing threshold performances of left ventricle pacing leads</measure>
    <time_frame>within 7 days after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>impedances performances of left ventricle pacing leads</measure>
    <time_frame>within 7 days after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications rate at 6 month Follow up</measure>
    <time_frame>Visit 6 : 6-months after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical benefit at 6 month Follow up: Gain in NYHA</measure>
    <time_frame>6-months after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical benefit at 6 month Follow up: 6 minutes walk test</measure>
    <time_frame>6-months after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical benefit at 6 month Follow up: quality of life questionnaire as compared to pre implantation</measure>
    <time_frame>6-months after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiography at 6 month Follow up: as compared to pre implantation for Left Ventricular Ejection Fraction</measure>
    <time_frame>6-months after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiography at 6 month Follow up: as compared to pre implantation for Left Ventricle volumes</measure>
    <time_frame>6-months after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiography at 6 month Follow up: as compared to pre implantation for mitral regurgitation</measure>
    <time_frame>6-months after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiography at 6 month Follow up: as compared to pre implantation for atrioventricular asynchronism</measure>
    <time_frame>6-months after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiography at 6 month Follow up: as compared to pre implantation for inter and intra-ventricular asynchronism</measure>
    <time_frame>6-months after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sensing performances of Left Ventricle pacing leads at 6 month Follow up</measure>
    <time_frame>6-months after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pacing threshold performances of Left Ventricle pacing leads at 6 month Follow up</measure>
    <time_frame>6-months after pacing procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>impedances performances of Left Ventricle pacing leads at 6 month Follow up</measure>
    <time_frame>6-months after pacing procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Heart Failure</condition>
  <condition>Cardiomyopathy, Dilated</condition>
  <condition>Coronary Disease</condition>
  <arm_group>
    <arm_group_label>Epicardial</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Endocardial</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Resynchronization using a transeptal approach</intervention_name>
    <description>Cardiac resynchronization with one in the right ventricle and one in the left ventricle via a transeptal puncture.
Devices used for procedure : Medtronic C304 or 6227DEF, Nykanen RF Wire, RADI PressureWire</description>
    <arm_group_label>Endocardial</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Resynchronization using a coronary sinus approach</intervention_name>
    <description>Cardiac resynchronization with one in the right ventricle and one in the left ventricle via the coronary sinus.
Devices used for procedure : RADI PressureWire, routine catheters chosen by operator</description>
    <arm_group_label>Epicardial</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (aged 18 or above)

          -  Cardiac insufficiency of whatever cause (ischemic or non-ischemic)

          -  Left ventricular ejection fraction &lt;35%

          -  NYHA Class III or IV with optimal medical treatment

          -  QRS duration &gt; 120 ms

          -  Sinus rhythm

          -  Patient must have signed informed consent

          -  Patient must be registered in the national health care system

        Exclusion Criteria:

          -  Aged under 18

          -  Patient with a mitral or aortic prosthesis

          -  Patient with contraindication to anti-coagulants

          -  Pregnant women

          -  Participation in another study

          -  Patient with contraindication for left ventricle catheterization by retrograde aortic
             approach , as a severe aortic stenosis requiring surgery, or an ascending aorta
             aneurism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre JAIS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Bordeaux, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre JAIS, MD</last_name>
    <phone>(0)5 57 65 64 71</phone>
    <phone_ext>+33</phone_ext>
    <email>pierre.jais@chu-bordeaux.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cardiologic Hospital Haut l'évêque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre JAIS, MD</last_name>
      <phone>(0)5 57 65 64 71</phone>
      <phone_ext>+33</phone_ext>
      <email>pierre.jais@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Maïder PIQUET</last_name>
      <phone>(0)5 56 79 56 79</phone>
      <phone_ext>+33</phone_ext>
      <email>maider.piquet@chu-bordeaux.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Pierre JAIS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre BORDACHAR, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe RITTER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arnaud DENIS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maxime DE GUILLEBON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2010</study_first_submitted>
  <study_first_submitted_qc>December 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2010</study_first_posted>
  <last_update_submitted>August 20, 2014</last_update_submitted>
  <last_update_submitted_qc>August 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>heart failure</keyword>
  <keyword>Cardiomyopathy, dilated</keyword>
  <keyword>Coronary disease</keyword>
  <keyword>Cardiac Pacing, Artificial</keyword>
  <keyword>cardiac resynchronization therapy</keyword>
  <keyword>Hemodynamics</keyword>
  <keyword>Randomized Controlled Trials</keyword>
  <keyword>Open Study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

